Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection
The FASEB Journal · 28.02.2025 · 39 (4)
DOI: 10.1096/fj.202402694r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 14.02.2025. Verfasst von Yannick Galipeau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, COVID-19, Autoantibodies, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR), Canadian Institutes of Health Research.
Abstract (Originalsprache)
Clinical outcomes resulting from SARS‐CoV‐2 infection vary widely, ranging from asymptomatic cases to the development of mild to severe respiratory illness, and in some instances, chronic lingering disease and mortality. The underlying biological mechanisms driving this wide spectrum of pathogenicity among certain individuals and demographics remain elusive. Autoantibodies have emerged as potential contributors to the severity of COVID‐19. Although preliminary reports have suggested the induction of antibodies targeting Angiotensin‐Converting Enzyme II (ACE2) post‐infection, this assertion lacks confirmation in large‐scale studies. In this study, our objective is to comprehensively characterize and quantify the prevalence and expression levels of autoantibodies directed against ACE2 in a sizable cohort ( n = 464). Our findings reveal that ACE2‐reactive IgM antibodies are the most prevalent, with an overall seroprevalence of 18.8%, followed by IgG at 10.3% and IgA at 6.3%. Longitudinal analysis of individuals with multiple blood draws showed stable ACE2 IgG and IgA levels over time. Upon stratifying individuals based on molecular testing for SARS‐CoV‐2 or serological evidence of past infection, no significant differences were observed between groups. Functional assessment of ACE2 autoantibodies demonstrated that they are non‐neutralizing and failed to inhibit spike‐ACE2 interaction or affect the enzymatic activity of ACE2. Our results highlight that ACE2 autoantibodies are prevalent in the general population and were not induced by SARS‐CoV‐2 infection in our cohort. Notably, we found no substantiated evidence supporting a direct role for ACE2 autoantibodies in SARS‐CoV‐2 pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, Ontario, Canada.
- Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Mayra Trentin Sonoda, Erin Collins, Kevin Burns, Curtis Cooper, Marc-André Langlois
Förderung
- Canadian Government | Canadian Institutes of Health Research (CIHR)
- Canadian Institutes of Health Research
Zitieren
APA
Galipeau, Y., Castonguay, N., McCluskie, P. S., Sonoda, M. T., Keeshan, A., Collins, E., Arnold, C., Pelchat, M., Burns, K., Cooper, C., & Langlois, M. A. (2025). Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection. The FASEB Journal, 39(4). https://doi.org/10.1096/fj.202402694r
Vancouver
Galipeau Y, Castonguay N, McCluskie PS, Sonoda MT, Keeshan A, Collins E, et al. Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection. The FASEB Journal. 2025;39(4). doi:10.1096/fj.202402694r
BibTeX
@article{Galipeau2025,
author = {Galipeau, Yannick and Castonguay, Nicolas and McCluskie, Pauline S and Sonoda, Mayra Trentin and Keeshan, Alexa and Collins, Erin and Arnold, Corey and Pelchat, Martin and Burns, Kevin and Cooper, Curtis and Langlois, Marc-André},
title = {Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {4},
doi = {10.1096/fj.202402694r}
}
EUVIMED